Role of the ubiquitin-proteasome system in cardiac dysfunction of adipose triglyceride lipase-deficient mice

Journal of Molecular and Cellular Cardiology

Volumn 77, Issue , 2014, Pages 11-19

  Mussbacher, Marion ^a   Stessel, Heike ^a   Wölkart, Gerald ^a   Haemmerle, Guenter ^a   Zechner, Rudolf ^a   Mayer, Bernd ^a   Schrammel, Astrid ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Adipose triglyceride lipase; Cardiac dysfunction; Inflammation; NF B; Peroxisome proliferator activated receptor

Indexed keywords

CHAPERONE; E1A PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOCHONDRIAL TRANSCRIPTION FACTOR A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PIRINIXIC ACID; PROTEASOME; PROTEIN DISULFIDE ISOMERASE; TRIACYLGLYCEROL LIPASE; UBIQUITIN; PYRIMIDINE DERIVATIVE; UBIQUITINATED PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DISULFIDE BOND; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENZYME DEFICIENCY; FEMALE; HEART DISEASE; HEART MUSCLE CELL; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRIGLYCERIDE LIPASE DEFICIENCY; UBIQUITINATION; UPREGULATION; AGONISTS; ANIMAL; C57BL MOUSE; DEFICIENCY; ENZYMOLOGY; GENE EXPRESSION; GENE INACTIVATION; GENETICS; HEART MUSCLE; KNOCKOUT MOUSE; METABOLISM;

MUS;

ANIMALS; APOPTOSIS; CARDIOMYOPATHIES; ENDOPLASMIC RETICULUM STRESS; FEMALE; GENE EXPRESSION; GENE KNOCKOUT TECHNIQUES; LIPASE; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; NF-KAPPA B; OXIDATIVE STRESS; PPAR ALPHA; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; PYRIMIDINES; SIGNAL TRANSDUCTION; UBIQUITINATED PROTEINS; UBIQUITINATION;

EID: 84908463508     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.09.028     Document Type: Article

References (34)

1. Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 2009, 78:477-513. 10.1146/annurev.biochem.78.081507.101607.
2. Predmore J.M., Wang P., Davis F., Bartolone S., Westfall M.V., Dyke D.B., et al. Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation 2010, 121:997-1004. 10.161/CIRCULATIONAHA.109.904557.
3. Tsukamoto O., Minamino T., Okada K., Shintani Y., Takashima S., Kato H., et al. Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice. Biochem Biophys Res Commun 2006, 340:1125-1133. 10.016/j.bbrc.2005.12.120.
4. Divald A., Powell S.R. Proteasome mediates removal of proteins oxidized during myocardial ischemia. Free Radic Biol Med 2006, 40:156-164. 10.1016/j.freeradbiomed.2005.09.022.
5. Powell S.R., Wang P., Katzeff H., Shringarpure R., Teoh C., Khaliulin I., et al. Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome. Antioxid Redox Signal 2005, 7:538-546. 10.1089/ars.2005.7.538.
6. Chen Q., Liu J.B., Horak K.M., Zheng H., Kumarapeli A.R., Li J., et al. Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake. Circ Res 2005, 97:1018-1026. 10.161/01.RES.0000189262.92896.0b.
7. Ling Y.H., Liebes L., Zou Y., Perez-Soler R. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J Biol Chem 2003, 278:33714-33723. 10.1074/jbc.M302559200.
8. Robinson E., Grieve D.J. Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease. Pharmacol Ther 2009, 122:246-263. 10.1016/j.pharmthera.2009.03.003.
9. Haemmerle G., Moustafa T., Woelkart G., Büttner S., Schmidt A., van de Weijer T., et al. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1. Nat Med 2011, 17:1076-1085. 10.38/nm.2439.
10. Zimmermann R., Strauss J.G., Haemmerle G., Schoiswohl G., Birner-Gruenberger R., Riederer M., et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 2004, 306:1383-1386. 10.126/science.1100747.
11. Haemmerle G., Lass A., Zimmermann R., Gorkiewicz G., Meyer C., Rozman J., et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006, 312:734-737. 10.1126/science.1123965.
12. Wölkart G., Schrammel A., Dörffel K., Haemmerle G., Zechner R., Mayer B. Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARα agonist. Br J Pharmacol 2012, 165:380-389. 10.1111/j.476-5381.2011.01490.x.
13. Schrammel A., Mussbacher M., Winkler S., Haemmerle G., Stessel H., Wölkart G., et al. Cardiac oxidative stress in a mouse model of neutral lipid storage disease. Biochim Biophys Acta 2013, 1831:1600-1608. 10.016/j.bbalip.2013.07.004.
14. Guellich A., Damy T., Conti M., Claes V., Samuel J.L., Pineau T., et al. Tempol prevents cardiac oxidative damage and left ventricular dysfunction in the PPAR-α KO mouse. Am J Physiol Heart Circ Physiol 2013, 304:H1505-H1512. 10.152/ajpheart.00669.2012.
15. Staels B., Koenig W., Habib A., Merval R., Lebret M., Torra I.P., et al. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature 1998, 393:790-793. 10.1038/31701.
16. Li Y., Zhu H., Kuppusamy P., Roubaud V., Zweier J.L., Trush M.A. Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J Biol Chem 1998, 273:2015-2023. 10.1074/jbc.273.4.2015.
17. Groenendyk J., Sreenivasaiah P.K., Kim do H., Agellon L.B., Michalak M. Biology of endoplasmic reticulum stress in the heart. Circ Res 2010, 107:1185-1197. 10.61/CIRCRESAHA.110.227033.
18. Gordon J.W., Shaw J.A., Kirshenbaum L.A. Multiple facets of NF-κB in the heart: to be or not to NF-κB. Circ Res 2011, 108:1122-1132. 10.61/CIRCRESAHA.110.226928.
19. Sasaki C.Y., Barberi T.J., Ghosh P., Longo D.L. Phosphorylation of RelA/p65 on serine 536 defines an IκBα-independent NF-κB pathway. J Biol Chem 2005, 280:34538-34547. 10.1074/jbc.M504943200.
20. Powell S.R., Davies K.J., Divald A. Optimal determination of heart tissue 26S-proteasome activity requires maximal stimulating ATP concentrations. J Mol Cell Cardiol 2007, 42:265-269. 10.1016/j.yjmcc.2006.10.010.
21. Kratky D., Obrowsky S., Kolb D., Radovic B. Pleiotropic regulation of mitochondrial function by adipose triglyceride lipase-mediated lipolysis. Biochimie 2014, 96:106-112. 10.1016/j.biochi.2013.06.023.
22. Majetschak M. Regulation of the proteasome by ATP: implications for ischemic myocardial injury and donor heart preservation. Am J Physiol Heart Circ Physiol 2013, 305:H267-H278. 10.1152/ajpheart.00206.2012.
23. Bulteau A.L., Lundberg K.C., Humphries K.M., Sadek H.A., Szweda P.A., Friguet B., et al. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 2001, 276:30057-30063. 10.1074/jbc.M100142200.
24. Barlaka E., Lédvenyiová V., Galatou E., Ferko M., Čarnická S., Ravingerová T., et al. Delayed cardioprotective effects of WY-14643 are associated with inhibition of MMP-2 and modulation of Bcl-2 family proteins through PPAR-α activation in rat hearts subjected to global ischaemia-reperfusion. Can J Physiol Pharmacol 2013, 91:608-616. 10.1139/cjpp-2012-0412.
25. Hwang J.J., Allen P.D., Tseng G.C., Lam C.W., Fananapazir L., Dzau V.J., et al. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics 2002, 10:31-44. 10.1152/physiolgenomics.00122.2001.
26. Severino A., Campioni M., Straino S., Salloum F.N., Schmidt N., Herbrand U., et al. Identification of protein disulfide isomerase as a cardiomyocyte survival factor in ischemic cardiomyopathy. J Am Coll Cardiol 2007, 50:1029-1037. 10.16/j.jacc.2007.06.006.
27. Fuchs C.D., Claudel T., Kumari P., Haemmerle G., Pollheimer M.J., Stojakovic T., et al. Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice. Hepatology 2012, 56:270-280. 10.1002/hep.25601.
28. Purcell N.H., Tang G., Yu C., Mercurio F., DiDonato J.A., Lin A. Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci U S A 2001, 98:6668-6673. 10.1073/pnas.111155798.
29. Aiken C.T., Kaake R.M., Wang X., Huang L. Oxidative stress-mediated regulation of proteasome complexes. Mol Cell Proteomics 2011, 10. [R110.006924]. 10.1074/mcp.M110.
30. Ishii T., Akagawa M., Naito Y., Handa O., Takagi T., Mori T., et al. Pro-oxidant action of pyrroloquinoline quinone: characterization of protein oxidative modifications. Biosci Biotechnol Biochem 2010, 74:663-666. 10.1271/bbb.90764.
31. Demasi M., Silva G.M., Netto L.E. 20 S proteasome from Saccharomyces cerevisiae is responsive to redox modifications and is S-glutathionylated. J Biol Chem 2003, 278:679-685. 10.1074/jbc.M209282200.
32. Demasi M., Shringarpure R., Davies K.J. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors. Arch Biochem Biophys 2001, 389:254-263. 10.1006/abbi.2001.332.
33. Stadtman E.R. Protein oxidation and aging. Free Radic Res 2006, 40:1250-1258. 10.080/10715760600918142.
34. Marfella R., Siniscalchi M., Portoghese M., Di Filippo C., Ferraraccio F., Schiattarella C., et al. Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity. Hypertension 2007, 49:784-791. 10.1161/01.HYP.0000259739.64834.d4.